在阿尔茨海默氏症和帕金森病中NOX2
Christopher M Dustin1, Sruti S Shiva1, Alberto Vazquez2
1Pittsburgh Heart, Lung, Blood and Vascular Medicine Institute, School of Medicine, University of Pittsburgh, Pittsburgh, PA, 15261, USA; Department of Pharmacology and Chemical Biology, School of Medicine, University of Pittsburgh, Pittsburgh, PA, 15261, USA.
Redox biology
|December 1, 2024
概括
阿尔茨海默病涉及脑组织损伤. 本综述探讨了NADPH氧化酶2 (NOX2) 如何促进阿尔茨海默氏症的进展,并讨论了潜在的NOX2向治疗方法.
科学领域:
- 神经科学是一个神经科学.
- 生物化学 生化学
- 病理学 病理学 病理学
背景情况:
- 阿尔茨海默氏症 (AD) 和相关的痴呆症正在增加全球健康问题.
- 阿尔茨海默病的特征是神经组织退化,粉样斑块和神经纤维状结.
- 反应性氧物种 (ROS) 和NADPH氧化酶蛋白与AD病原发生有关.
研究的目的:
- 审查NADPH氧化酶2 (NOX2) 在阿尔茨海默病进展中的作用.
- 检查NOX2对AD中神经元,微质和脑血管信号的贡献.
- 讨论新兴的NOX2向治疗方法来治疗AD.
主要方法:
- 关于NOX2和阿尔茨海默病的最新研究的文献综述.
- 对研究NOX2在AD相关的细胞和血管通路中的作用的研究分析.
- 综合了针对NOX2.2的治疗策略的研究结果.
主要成果:
- NOX2与与AD发展相关的血管和炎症过程密切相关.
- 在AD的背景下,NOX2活动影响神经元,微质和脑血管信号.
- 有证据表明NOX2是AD进展的重要因素.
结论:
- NOX2在阿尔茨海默氏病的发病过程中起着至关重要的作用.
- 向NOX2为管理和治疗AD提供了一个有希望的治疗途径.
- 对NOX2通路的进一步研究对于开发有效的AD干预措施至关重要.
相关概念视频
Neural Regulation
39.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.1K
Parkinson's Disease: Overview
482
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
482
Alzheimer's Disease: Overview
448
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
448
Parkinson's Disease: Treatment
220
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
220


